Impaired target site penetration of &bgr; -lactams may account for therapeutic failure in patients with septic shock

ObjectiveCurrent guidelines for adjusting antimicrobial therapy regimens commonly are based on drug concentrations measured in plasma. In septic patients, however, the interstitial space of soft tissues in addition to the central compartment represents the target site of infection. We thus hypothesized that one explanation for therapeutic failure during antibiotic treatment might be the inability to achieve effective antimicrobial concentrations in the interstitial space fluid of soft tissues. This is corroborated by the fact that piperacillin, a frequently administered &bgr;-lactam antibiotic, often fails to be effective despite documented susceptibility of the causative pathogen in vitro. DesignProspective comparative study of two groups. SettingThe intensive care unit and research ward of an university hospital. SubjectsSix patients with septic shock and a control group of six gender- and age-matched healthy volunteers. InterventionsTo measure piperacillin penetration into the interstitial space fluid of skeletal muscle and subcutaneous adipose tissue, we employed microdialysis after a single intravenous administration of 4.0 g of piperacillin to patients and healthy volunteers. Piperacillin concentrations were assayed by using reversed-phase high-pressure liquid chromatography. Measurements and Main Results In septic shock patients, interstitial piperacillin concentrations in skeletal muscle and subcutaneous adipose tissue were five- to ten-fold lower than corresponding free plasma concentrations (p < .03). Mean piperacillin concentrations in subcutaneous adipose tissue never exceeded 11 &mgr;g/mL, which is below the minimal inhibitory concentration for a range of relevant pathogens in patients with septic shock. ConclusionThe results of the present study demonstrate that in septic shock patients, piperacillin concentrations in the interstitial space may be subinhibitory, even though effective concentrations are attained in plasma. The lack of success of antimicrobial therapy in these patients thus might be attributable to inadequate target site penetration of antibiotics.

[1]  P. Dodek,et al.  Distribution of normal saline and 5% albumin infusions in septic patients. , 1999, Critical care medicine.

[2]  B. Meyers,et al.  Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics , 1980, Antimicrobial Agents and Chemotherapy.

[3]  T. Terasaki,et al.  Effect of extracellular water volume on the distribution kinetics of beta-lactam antibiotics as a function of age. , 1985, Journal of pharmacobio-dynamics.

[4]  H. Schassan,et al.  Penetration of eight beta-lactam antibiotics into the peritoneal fluid. A pharmacokinetic investigation. , 1983, Archives of surgery.

[5]  M. Weil,et al.  Treatment of circulatory shock. Use of sympathomimetic and related vasoactive agents. , 1975, JAMA.

[6]  M. Jacobs,et al.  Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes , 1994, Antimicrobial Agents and Chemotherapy.

[7]  M. Kinzig,et al.  Pharmacokinetics and tissue penetration of piperacillin/tazobactam with particular reference to its potential in abdominal and soft tissue infections. , 1994, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[8]  Jerome J. Schentag,et al.  Principles of antibiotic tissue penetration and guidelines for pharmacokinetic analysis. , 1982, The Medical clinics of North America.

[9]  K. Rand,et al.  Determination of free extracellular concentrations of piperacillin by microdialysis. , 1996, Journal of pharmaceutical sciences.

[10]  Jerome J. Schentag,et al.  Mathematical Examination of Dual Individualization Principles (I): Relationships between AUC above MIC and Area under the Inhibitory Curve for Cefmenoxime, Ciprofloxacin, and Tobramycin , 1991, DICP : the annals of pharmacotherapy.

[11]  C. Sprung,et al.  The ACCP-SCCM consensus conference on sepsis and organ failure. , 1992, Chest.

[12]  J. E. Carceller Practice parameters for hemodynamic support of sepsis in adult patients in sepsis , 1999 .

[13]  H. Eichler,et al.  Surgery and intensive care procedures affect the target site distribution of piperacillin , 2000, Critical care medicine.

[14]  G. Rolinson,et al.  Effect of protein binding on antibiotic activity in vivo. , 1983, The Journal of antimicrobial chemotherapy.

[15]  M. Andréjak,et al.  Pharmacokinetics and ascitic fluid penetration of piperacillin in cirrhosis , 1991, Fundamental & clinical pharmacology.

[16]  D. M. Ryan Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans. , 1993, The Journal of antimicrobial chemotherapy.

[17]  K. Burgess,et al.  Penetration of piperacillin into bronchial mucosa and sputum. , 1981, Thorax.

[18]  K. Ilett,et al.  Pharmacokinetics of Drugs Used in Critically Ill Adults , 1998, Clinical pharmacokinetics.

[19]  J. Vincent,et al.  Has the mortality of septic shock changed with time. , 1998, Critical care medicine.

[20]  D. M. Ryan,et al.  The use of antibiotic serum levels to predict concentrations in tissues. , 1986, Scandinavian journal of infectious diseases.

[21]  Ryan Dm Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans , 1993 .

[22]  Jerome J. Schentag,et al.  The Importance of Pharmacokinetic/Pharmacodynamic Surrogate Markers to Outcome , 1995, Clinical pharmacokinetics.

[23]  H. Eichler,et al.  Application of microdialysis to clinical pharmacokinetics in humans , 1995, Clinical pharmacology and therapeutics.

[24]  P. Jansson,et al.  A microdialysis method allowing characterization of intercellular water space in humans. , 1987, The American journal of physiology.

[25]  H. Eichler,et al.  Drug Distribution , 1998, Clinical pharmacokinetics.

[26]  R. Wise,et al.  The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics. , 1980, The Journal of infectious diseases.

[27]  D. M. Ryan,et al.  A problem in the interpretation of β-lactam antibiotic levels in tissues , 1983 .

[28]  H. Pehamberger,et al.  Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans , 1996, Antimicrobial agents and chemotherapy.

[29]  C. Sanders,et al.  Piperacillin/tazobactam: a critical review of the evolving clinical literature. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.